Lawrence Mahan Ph.D.
(President of BioConsult USA, Bethesda MD.)
Dr. Mahan is president of BioConsult USA providing professional consulting services to the biopharmaceutical industry as well as for commercialization opportunities in the academic translational research environment. He is a successful business professional in the innovation management of advanced biomedical technologies; having acted within and outside organizations to accelerate their mission and strategic vision. His specialties include technology evaluation, venture diligence, entrepreneur guidance, policy and legislation development, and business strategy creation with a domestic and international track record in business alliance development. His business expertise builds upon more than 20 years as an accomplished senior scientist in biomedical research including 12 years at the National Institute of Health. He has authored more than 100 published articles and abstracts and holds four US patents. His research has encompassed cellular and molecular biology, pharmacology, functional genomics, proteomics, neuroscience, immunology and biochemistry with additional experience in biomedical device engineering principals, bioinformatics and IT architectural management. Dr. Mahan has served in various roles including Director of the Office of Translational Alliances and Coordination at the National Heart, Lung and Blood Institute, Director of Innovation and Business Development for Children’s National Medical Center, Executive Director of the Maryland Biotechnology Center, and leading life sciences business development at Maryland’s Department of Business & Economic Development as Director of Biosciences & Advanced Technologies and Senior Strategy Advisor to the Office of the Governor. Dr. Mahan holds a degree in Physiology and Pharmacology from the University of California, San Diego. He has been an invited speaker globally on his scientific research and industry development in the biosciences.